Trials in rheumatoid arthritis: choosing the right outcome measure when minimal disease is achievable.
Felson
David T
DT
Clinical Epidemiology Unit, Boston University School of Medicine, 650 Albany Street, Boston, MA 02118, USA. dfelson@bu.edu
Zhang
Bin
B
Siegel
Jeffrey N
JN
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D018579:Patient Selection; D012074:Remission Induction; D016896:Treatment Outcome
D018501:Antirheumatic Agents